Wyndham H Wilson, M.D., MD, PhD

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Primary effusion lymphoma→
• Acromesomelic dysplasia→
• Genetic bone tumor→
• Subcutaneous panniculitis-like T-cell lymphoma→
• B-cell chronic lymphocytic leukemia→
• Mantle cell lymphoma→
• HIV-associated cancer→
• B-cell non-Hodgkin lymphoma→
• Aggressive NK-cell leukemia→

Clinical trials (8)

• NCT00001563
• NCT00114738
• NCT01445535
• NCT01415765
• NCT00069238
• NCT00022971
• NCT01030900
• NCT00001586

Verify independently

• ClinicalTrials.gov PI search for Wyndham H Wilson, M.D.
• NPPES NPI registry entry

Other specialists for Primary effusion lymphoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Richard F. Little, MD
  NCI - HIV and AIDS Malignancy Branch
• Robert Yarchoan, M.D.
  National Cancer Institute (NCI)
  Maryland
• Ramya M Ramaswami, M.D.
  National Cancer Institute (NCI)
  Maryland
• Pei Wang, PhD
  Eureka Therapeutics Inc.
• Stephen M Ansell, M.D
  Dana-Farber - Harvard Cancer Center LAO
  MN
• Frank G Basile, M.D., MD
  Schrodinger Inc.
  RI
• Amrita Krishnan, MD
  City of Hope Medical Center
  CA
• Ramya Ramaswami, M.D., MD MPH
  National Cancer Institute (NCI)
  MD

See all specialists for Primary effusion lymphoma →